-
Signature
-
/s/ Ian A. Johnston, Attorney-in-Fact for Rohit Ramchandani
-
Stock symbol
-
PFMT
-
Transactions as of
-
Sep 7, 2023
-
Transactions value $
-
-$32,246
-
Form type
-
4
-
Date filed
-
9/11/2023, 07:28 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
PFMT |
Common Stock, par value $0.0001 per share |
Options Exercise |
$0 |
+15.5K |
+10.74% |
$0.00 |
160K |
Sep 7, 2023 |
Direct |
|
transaction |
PFMT |
Common Stock, par value $0.0001 per share |
Tax liability |
-$12.9K |
-5.37K |
-3.35% |
$2.41 |
155K |
Sep 7, 2023 |
Direct |
F1 |
transaction |
PFMT |
Common Stock, par value $0.0001 per share |
Options Exercise |
$0 |
+23.2K |
+14.97% |
$0.00 |
178K |
Sep 7, 2023 |
Direct |
|
transaction |
PFMT |
Common Stock, par value $0.0001 per share |
Tax liability |
-$19.3K |
-8.01K |
-4.5% |
$2.41 |
170K |
Sep 7, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
PFMT |
Restricted Stock Units |
Options Exercise |
|
-15.5K |
-33.33% |
|
31.1K |
Sep 7, 2023 |
Common Stock |
15.5K |
$0.00 |
Direct |
F2, F3 |
transaction |
PFMT |
Restricted Stock Units |
Options Exercise |
|
-23.2K |
-25% |
|
69.5K |
Sep 7, 2023 |
Common Stock |
23.2K |
$0.00 |
Direct |
F2, F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: